Cario - Centre Armoricain de Radiothérapie, Imagerie Médicale Et Oncologie

Plérin 22190

0 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumor, Metastatic Solid Tumors, Solid Cancer, Triple Negative Breast Neoplasms, Uterine Cervical Neoplasms

Studies at this site

• A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Recruiting now
• A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01) — Running, not enrolling
• Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer — Completed
• Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer — Stopped early